The above article, first published online on May 27, 2018, in Wiley Online Library (https://onlinelibrary.wiley.com/doi/full/10.1111/cns.12981), has been retracted as requested by the journal's editorial team and with the agreement of John Wiley & Sons Ltd. The retraction has been agreed following a formal investigation into the allegation of potential scientific misconduct, which revealed that several image elements of the experimental data were published elsewhere in a different scientific context or repeatedly used within the images. Thus, the editors consider the conclusions of this article to be invalid. The authors were not available to comment on these inconsistencies despite of multiple inquires by the journal.
. 2021 Jul 30;27(9):1099. doi: 10.1111/cns.13709
Retraction: “MicroRNA‐219 decreases hippocampal long‐term potentiation inhibition and hippocampal neuronal cell apoptosis in type 2 diabetes mellitus mice by suppressing the NMDAR signaling pathway,” by Zhang, L, Chen, Z‐W, Yang, S‐F, et al. CNS Neurosci Ther. 2019; 25: 69–77
Collection date 2021 Sep.
© 2021 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC12893199 PMID: 40908590
This retracts the article "MicroRNA‐219 decreases hippocampal long‐term potentiation inhibition and hippocampal neuronal cell apoptosis in type 2 diabetes mellitus mice by suppressing the NMDAR signaling pathway" in volume 25 on page 69.
